Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.33% | $4.14M | €443.79B | 76.85% | 76 Outperform | |
| Roche Holding AG | 1.42% | $2.52M | CHF283.97B | 35.98% | 73 Outperform | |
| AstraZeneca | 1.38% | $2.44M | $312.86B | 25.09% | 80 Outperform | |
| Novartis AG | 1.37% | $2.43M | CHF240.57B | 27.68% | 80 Outperform | |
| HSBC Holdings | 1.30% | $2.30M | £221.80B | 39.10% | 80 Outperform | |
| Toyota Motor | 1.24% | $2.20M | ¥48.25T | 23.53% | 80 Outperform | |
| Nestlé SA | 1.19% | $2.12M | CHF205.50B | 4.42% | 71 Outperform | |
| Shell (UK) | 1.07% | $1.90M | £175.51B | 21.16% | 73 Outperform | |
| Royal Bank Of Canada | 1.03% | $1.83M | $232.31B | 44.14% | 75 Outperform | |
| Mitsubishi UFJ Financial Group | 0.95% | $1.68M | ¥31.03T | 35.36% | 76 Outperform |